Manufacturers should have issued a Cartiva recall after discovering high failure rates with the toe implant, according to allegations being prepared for trial.
Manufacturer failed to issue a Cartiva SCI recall even after receiving nearly 150 reports of implant failures and device loosening, according to the lawsuit.
A Texas man blames the Cartiva implant failure on a lack of adequate testing by the manufacturers, who he says hid the device's failings from the public.
More than a quarter of Cartiva toe implant recipients expressed dissatisfaction with the procedure, with less than 40% reporting being satisfied with the results.
Fusion of her big toe left plaintiff with decreased flexibility, and the Cartiva implant lawsuit indicates she will need additional reconstructive surgery.
Lawsuits allege design problems with Cartiva toe implants cause complications after surgery, often resulting in additional procedures, loss of mobility and worse long-term outcomes for big toe pain.
Michigan appeals court determined plaintiff's expert witness presented sufficient evidence to allow a jury to consider the the Cartiva implant malpractice lawsuit
Plaintiffs each dismissed their lawsuits shortly after they were filed, raising speculation that the manufacturer may have reached Cartiva toe implant settlements or agreed to a tolling agreement to extend the statute of limitations
Studies and reports have found Cartiva toe implants fail at rates much higher than the manufacturer disclosed, leading to a number of Cartiva lawsuits
Cartiva toe implants have been linked to a number of complications, including implant failures which resulted in the need for revision surgery and joint fusion.
